telmisartan has been researched along with Diabetic Retinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imaizumi, T; Inoue, H; Matsui, T; Nakamura, K; Takeuchi, M; Yamagishi, S | 1 |
| Nakamura, K; Yamagishi, S | 1 |
| Matsui, T; Nakamura, K; Okuda, S; Ueda, S; Yamagishi, S | 1 |
2 review(s) available for telmisartan and Diabetic Retinopathy
| Article | Year |
|---|---|
Telmisartan, its potential therapeutic implications in cardiometabolic disorders.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetic Retinopathy; Humans; Insulin Resistance; PPAR gamma; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Telmisartan | 2006 |
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Oxidative Stress; PPAR gamma; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Telmisartan | 2008 |
1 other study(ies) available for telmisartan and Diabetic Retinopathy
| Article | Year |
|---|---|
Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Cells, Cultured; Diabetic Retinopathy; Glycation End Products, Advanced; NF-kappa B; Pericytes; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptor, Angiotensin, Type 1; Receptors, Immunologic; Retina; RNA, Messenger; Telmisartan; Up-Regulation | 2005 |